OVERVIEW
The seed of Symbiotec’s longstanding passion for pharmaceuticals was sown with the setting up of a laboratory in 1995, from then to now, we have remained true to the dream of offering quality APIs to ensure quality healthcare solutions and we hope to continue doing so even as we expand our reach.
- 1995
Set up of Laboratory for production of Cortico-Steroids APIs.
- 2004
Set up of Industrial scale Manufacturing Plant in Rau, Indore
- 2008
First EU GMP Certification of RAU Site.
- 2009
Successful US-FDA inspection of Rau Steroids API plant
Commissioning of the SEZ unit
Start of commercial production of- a) Cortico-Steroids
- b) Steroid-Hormones APIs
- 2011
Commencement of fermentation activities from Biotech Facility at SEZ unit.
Infusion of Capital by private equity ‘Franklin Tempelton’ - 2012
Accreditation by US-FDA SEZ site & Re-accreditation by US-FDA of Rau site
- 2013
Infusion of Capital by private equity ‘Actis’.
Eu-GMP Certification of Sterile Manufacturing Facility, Rau Site and Eu-GMP Certification of SEZ Site. - 2014
Re-Accreditation by US –FDA, Rau Site.
- 2015
Commencement of Large Scale Chemical Synthesis Plant in June 2015, with batch size up to 1000 Kg.
- Re-Accreditation by US-FDA of SEZ Site.
- Re-Qualification of Eu-GMP certification of RAU site and SEZ site.
- 2017
Re-accreditation by US – FDA
- 2018
Key Developments Re-Qualification of Eu-GMP certification of RAU Site and SEZ Site.
Infusion of Capital by Private Equity, ‘Motilal Oswal Private Equity (MOPE)’ and ‘InvAscent’. - 2019
Commissioning of a new corticosteroid block at Rau Unit
- 2021
Commissioning of a new sterile corticosteroid block at Rau Unit
